Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
10.68
-0.31 (-2.82%)
Nov 20, 2024, 4:00 PM EST - Market closed
Atara Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 61 | 52 | 311 | 1,393 | 1,626 | 892 | |
| Market Cap Growth | -69.17% | -83.21% | -77.67% | -14.28% | 82.28% | -43.76% | |
| Enterprise Value | 43 | 12 | 122 | 1,061 | 1,312 | 625 | |
| Last Close Price | 10.68 | 12.82 | 82.00 | 394.00 | 490.75 | 411.75 | |
| PS Ratio | 0.63 | 6.10 | 4.90 | 68.51 | - | - | |
| PB Ratio | -0.51 | -0.53 | 2.46 | 4.98 | 3.52 | 3.07 | |
| P/TBV Ratio | - | - | 2.46 | 4.98 | 3.52 | 3.07 | |
| EV/Sales Ratio | 0.43 | 1.36 | 1.93 | 52.15 | - | - | |
| Debt / Equity Ratio | -0.39 | -0.61 | 0.57 | 0.10 | 0.03 | 0.05 | |
| Asset Turnover | 0.61 | 0.03 | 0.15 | 0.04 | - | - | |
| Inventory Turnover | 23.00 | 40.39 | - | - | - | - | |
| Quick Ratio | 0.44 | 0.61 | 3.60 | 3.52 | 6.06 | 7.05 | |
| Current Ratio | 0.59 | 0.72 | 3.74 | 3.64 | 6.31 | 7.43 | |
| Return on Equity (ROE) | - | -2014.86% | -112.39% | -91.69% | -81.43% | -92.43% | |
| Return on Assets (ROA) | -46.93% | -62.11% | -40.64% | -40.29% | -41.49% | -50.30% | |
| Return on Capital (ROIC) | - | -210.90% | -67.79% | -54.20% | -49.28% | -57.22% | |
| Earnings Yield | -219.74% | -528.31% | -73.36% | -24.41% | -18.86% | -32.63% | |
| FCF Yield | -371.56% | -88.25% | -16.58% | -11.40% | -27.06% | |
| Buyback Yield / Dilution | -40.73% | -3.85% | -8.88% | -26.63% | -44.17% | -17.11% | |
| Total Shareholder Return | -40.73% | -3.85% | -8.88% | -26.63% | -44.17% | -17.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.